Top compounds associated with response to SETD9


Feature Type Standardized
Nominal ANOVA
mRNA CIL55 CTRPv2 pan-cancer AAC 0.026 0.7
mRNA linifanib CTRPv2 pan-cancer AAC 0.015 0.7
mRNA regorafenib CTRPv2 pan-cancer AAC 0.016 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA Erlotinib CCLE pan-cancer AAC 0.019 0.7
mRNA JW-480 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA BX-795 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA Pyrimethamine GDSC1000 pan-cancer AAC -0.022 0.7
mRNA thalidomide CTRPv2 pan-cancer AAC -0.022 0.7
mRNA CGP-082996 GDSC1000 pan-cancer AAC 0.021 0.7
Download CSV